Analysis of the prognostic efficacy of syndecan-1 for patients with ACLF and its functional role in liver regeneration
Collectively, our findings suggest that SDC-1 represents a potential prognostic and therapeutic target for ACLF and should be further investigated.
Authors
- Yichen Yao (ORCID: https://orcid.org/0009-0000-1378-7170)
- Tianzhi Ni
- Ruojing Wang
- Yuan Yang
- Yalei Zhao (ORCID: https://orcid.org/0000-0003-3436-0517)
- Jinfeng Liu
- Yuan Ping Feng (ORCID: https://orcid.org/0000-0003-2190-2284)
- Yingli He (ORCID: https://orcid.org/0000-0002-6439-012X)
- Fu Shan
- Xiaoli Zhang (ORCID: https://orcid.org/0000-0002-0770-5594)
- Yushan Liu (ORCID: https://orcid.org/0000-0002-1773-5463)
- Qiao Zhang (ORCID: https://orcid.org/0000-0003-4588-6813)
- Shihua Zhao (ORCID: https://orcid.org/0000-0003-1339-7476)
- Zhijun Liu (ORCID: https://orcid.org/0000-0003-2323-462X)
- Juan Li (ORCID: https://orcid.org/0000-0001-7995-7806)
Institutions
- National Health and Family Planning Commission (CN)
- Nanfang Hospital (CN)
- Xi'an Medical University (CN)
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- People's Government of Shaanxi Province (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- BMC Medicine
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1186/s12916-025-03931-4
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities